berberine has been researched along with dihydroberberine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czerniecki, NJ; Douglas, KA; Grundt, P; Krivogorsky, B; Pernat, JA | 1 |
| KONDO, Y; TAKEMOTO, T | 1 |
| Dong, XP; Feng, YL; Yu, BY | 1 |
| Cheng, Z; Cooney, GJ; Gosby, A; Hu, LH; James, DE; Kraegen, EW; Li, J; Li, JY; Miyoshi, H; Taketo, MM; To, SW; Turner, N; Ye, JM | 1 |
| Chen, AF; Cheng, Z; Gu, M; Hu, LH; Li, J; Li, JY; Li, YY; Sheng, L; Wu, F; Zhang, HK; Zhang, LN | 1 |
| Donahue, JP; Payton-Stewart, F; Pingali, S | 1 |
| Dong, S; Wei, SC; Xu, LJ; Zhang, CY | 1 |
| Chen, G; Dong, H; Huang, ZY; Liu, DL; Lu, FE; Luo, YH; Wang, KF; Xu, LJ; Zou, X | 1 |
| Chen, X; Chen, Y; Feng, R; Fu, J; He, CY; Huang, M; Jiang, JD; Li, XY; Lin, Y; Ma, C; Ren, G; Shou, JW; Tan, XS; Wang, Y; Wen, BY; Yang, XY; You, XF; Zhao, ZX | 1 |
| Bianucci, AM; Borghini, A; Pietra, D | 1 |
| Deng, AJ; Li, J; Li, ZH; Qin, HL; Song, HR; Wang, WJ; Wu, LQ; Zhang, HJ; Zhang, ZH | 1 |
| Dai, B; Liu, R; Ma, Y; Wang, W; Zhan, Y; Zhang, D; Zhang, Y | 1 |
| Fang, L; Li, B; Lv, L; Wang, J; Yu, D; Zhan, G; Zhang, B; Zhao, L; Zhao, X | 1 |
| Azike, CG; Baranowski, DC; Buchanan, B; Gabriele, J; Meng, Q; Poulin, MM; Zuccolo, J | 1 |
| Ai, G; Chen, H; Chen, J; Li, C; Luo, C; Su, Z; Tan, L; Wang, Y; Xie, J; Zeng, H | 1 |
| Deng, T; Hu, S; Huang, XA; Li, Y; Ling, Y; Liu, F; Peng, G; Wang, X; Wu, S | 1 |
| Chang, L; Figeys, D; Li, L; Liu, J; Mayne, J; Ning, Z; Stintzi, A; Ye, Y; Zhang, X | 1 |
| Cao, X; Cong, L; Fu, J; Gao, TL; Han, P; Jiang, JD; Li, XY; Lin, Y; Ma, SR; Pan, LB; Peng, R; Shou, JW; Tong, Q; Wang, Y; Wen, BY; Yu, H; Yu, JB; Zhang, XF; Zhang, ZW; Zhao, ZX | 1 |
| Dong, N; Li, C; Lu, Q; Mo, Z; Wu, B; Xie, J | 1 |
| Falk, M; Lewis, KD | 1 |
20 other study(ies) available for berberine and dihydroberberine
| Article | Year |
|---|---|
Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii.
Topics: Antiparasitic Agents; Berberine; Cells, Cultured; Inhibitory Concentration 50; Toxoplasma | 2012 |
[Reactions of protoberberine-type alkaloids. I. Reaction of dihydroberberine with alkylhalide].
Topics: Alkaloids; Berberine; Berberine Alkaloids; Halogens | 1962 |
[Simultaneous determination of three kinds of components in sanhuang tablets by high-performance liquid chromatography].
Topics: Anthraquinones; Berberine; Chromatography, High Pressure Liquid; Coptis; Drug Combinations; Drugs, Chinese Herbal; Emodin; Flavanones; Flavonoids; Plants, Medicinal; Quality Control; Reproducibility of Results; Rheum; Scutellaria baicalensis; Tablets | 2006 |
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Topics: Adenylate Kinase; Animals; Berberine; Cyclic Nucleotide-Regulated Protein Kinases; Electron Transport Complex I; Enzyme Activation; Insulin; Male; Mice; Mice, Inbred C57BL; Mitochondria, Muscle; Phosphorylation; Rats; Rats, Wistar | 2008 |
8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
Topics: Animals; Berberine; Diabetes Mellitus; Electron Transport; Glucose; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mitochondria; Obesity; Rats; Rats, Sprague-Dawley; Solubility | 2010 |
Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine.
Topics: Berberine; Crystallography, X-Ray; Hydrogen Bonding; Models, Molecular; Solvents | 2014 |
Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine.
Topics: Absorption; Animals; Berberine; Carbohydrate Metabolism; Carbohydrates; Chromatography, High Pressure Liquid; Glucose; Intestinal Absorption; Rats | 2014 |
Inhibition of proprotein convertase subtilisin/kexin type 9: a novel mechanism of berberine and 8-hydroxy dihydroberberine against hyperlipidemia.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Berberine; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Lipids; Liver; Male; Proprotein Convertase 9; Rats, Wistar; Receptors, LDL; Serine Endopeptidases; Sterol Regulatory Element Binding Protein 2 | 2015 |
Transforming berberine into its intestine-absorbable form by the gut microbiota.
Topics: Administration, Oral; Animals; Bacteria; Bacterial Proteins; Berberine; Binding Sites; Chromatography, High Pressure Liquid; Gastrointestinal Microbiome; Hypoglycemic Agents; Intestinal Absorption; Intestines; Male; Mice; Molecular Docking Simulation; Nitroreductases; Oxidation-Reduction; Rats, Sprague-Dawley; Solubility; Tandem Mass Spectrometry | 2015 |
In vitro studies of antifibrotic and cytoprotective effects elicited by proto-berberine alkaloids in human dermal fibroblasts.
Topics: Berberine; Berberine Alkaloids; Cell Proliferation; Cells, Cultured; Collagen; Cytoprotection; Fibroblasts; Fibrosis; Free Radicals; Humans; Hydrogen Peroxide; Interleukin-1beta; Interleukin-6; Mitochondria; Oxidoreductases; Protective Agents; Transforming Growth Factor beta1 | 2015 |
Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents.
Topics: Berberine; Colitis, Ulcerative; Hydrastis; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Regulatory Factor X Transcription Factors; Salts | 2016 |
Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators.
Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Indoles; Inflammation Mediators; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Pyrroles; Sunitinib; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells.
Topics: Action Potentials; Activating Transcription Factor 6; Berberine; Calnexin; Calreticulin; Drug Design; Ether-A-Go-Go Potassium Channels; Gene Expression Regulation; HEK293 Cells; HSP90 Heat-Shock Proteins; Humans; Patch-Clamp Techniques; Phenylalanine; Protein Folding; Protein Transport; Tyrosine; Unfolded Protein Response | 2017 |
Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
Topics: Administration, Cutaneous; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Berberine; Calibration; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Half-Life; Kidney; Limit of Detection; Liver; Male; Rats; Rats, Sprague-Dawley; Simvastatin; Tandem Mass Spectrometry | 2018 |
Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Berberine; Capillary Permeability; Carrageenan; Cytokines; Edema; Female; Foot; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Phellodendron; Plant Bark; Xylenes | 2019 |
A new fluorescent probe for sensing of biothiols and screening of acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Berberine; Boron Compounds; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Elasmobranchii; Electric Fish; Fluorescent Dyes; Glutathione; Limit of Detection; Molecular Docking Simulation; Protein Binding; Styrenes; Tacrine | 2020 |
Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes.
Topics: Bacterial Proteins; Bacteroidetes; Berberine; Biological Variation, Population; Butyrates; Firmicutes; Gastrointestinal Microbiome; Humans; Metabolic Networks and Pathways; Molecular Structure; Proteobacteria; Proteomics; Verrucomicrobia | 2020 |
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Topics: Animals; Berberine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enterococcus faecalis; Enterococcus faecium; Gastrointestinal Microbiome; Humans; Levodopa; Mice; Parkinson Disease; Tyrosine 3-Monooxygenase | 2021 |
Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice.
Topics: Animals; Berberine; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Isoquinolines; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Phytochemicals; Protective Agents; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Toxicological assessment of dihydroberberine.
Topics: Animals; Berberine; Female; Lethal Dose 50; Male; Mice; Micronucleus Tests; No-Observed-Adverse-Effect Level; Rats; Rats, Sprague-Dawley | 2022 |